These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 2998993)

  • 1. The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines.
    Steel CM; Morten JE; Foster E
    IARC Sci Publ; 1985; (60):265-92. PubMed ID: 2998993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
    Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
    Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines.
    Karpova MB; Schoumans J; Blennow E; Ernberg I; Henter JI; Smirnov AF; Nordenskjöld M; Fadeel B
    Int J Oncol; 2006 Mar; 28(3):605-17. PubMed ID: 16465364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective loss of integrated Epstein-Barr virus genomes after long-term cultivation of Burkitt's lymphoma x B-lymphoblastoid cell hybrids due to chromatin instability at the integration site.
    Wolf J; Jox A; Skarbek H; Pukrop T; Bartnitzke S; Pawlita M; Diehl V; Bullerdiek J
    Virology; 1995 Sep; 212(1):179-85. PubMed ID: 7676627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
    Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
    Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetics of Burkitt's lymphoma-leukaemia: a review.
    Berger R; Bernheim A
    IARC Sci Publ; 1985; (60):65-80. PubMed ID: 2998996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is there a functional equivalence between abnormalities of the long arm of chromosome 1 and the presence of Epstein-Barr virus in continuous lines of Burkitt's lymphoma?].
    Berger R; Bernheim A
    C R Acad Sci III; 1984; 298(6):143-5. PubMed ID: 6324967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome aberrations acquired in vitro by human B-cell lines. II. Distribution of break points.
    Shade M; Woodward MA; Steel CM
    J Natl Cancer Inst; 1980 Jul; 65(1):101-9. PubMed ID: 6967123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell maturation stages of Burkitt's lymphoma cell lines according to Epstein-Barr virus status and type of chromosome translocation.
    Cohen JH; Revillard JP; Magaud JP; Lenoir G; Vuillaume M; Manel AM; Vincent C; Bryon PA
    J Natl Cancer Inst; 1987 Feb; 78(2):235-42. PubMed ID: 3027441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics.
    Magrath IT; Pizzo PA; Whang-Peng J; Douglass EC; Alabaster O; Gerber P; Freeman CB; Novikovs L
    J Natl Cancer Inst; 1980 Mar; 64(3):465-76. PubMed ID: 6243721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of the Epstein-Barr virus DNA in three new Burkitt's lymphoma-derived cell lines.
    Harris A; Walsh-Arrand JE; Crawford DH; Lenoir GM; Griffin BE
    Mol Biol Med; 1984 Apr; 2(2):135-50. PubMed ID: 6099862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biology and serology of Epstein-Barr virus (EBV) infections.
    Klein G
    Bull Cancer; 1976; 63(3):399-410. PubMed ID: 187269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterisation of two novel human KSHV- and EBV-negative Burkitt cell lines, GAL-01 and GAL-02, from a primary lymphomatous effusion.
    Thielen C; Herens C; Fassotte MF; Detrooz E; Drion P; Diss T; Boniver J; de Leval L
    Eur J Haematol; 2006 Oct; 77(4):318-26. PubMed ID: 16856916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversion of tumorigenicity in an EBV-converted Burkitt's lymphoma line.
    Klein G
    Ciba Found Symp; 1989; 142():36-48; discussion 48-53. PubMed ID: 2545422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human B-lymphoid cell lines.
    Nilsson K
    Hum Cell; 1992 Mar; 5(1):25-41. PubMed ID: 1329931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of lymphomatous cell lines from bone marrow samples from patients with Burkitt's lymphoma.
    Philip I; Philip T; Favrot M; Vuillaume M; Fontaniere B; Chamard D; Lenoir GM
    J Natl Cancer Inst; 1984 Oct; 73(4):835-40. PubMed ID: 6090749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus and oncogenesis: from latent genes to tumours.
    Young LS; Murray PG
    Oncogene; 2003 Aug; 22(33):5108-21. PubMed ID: 12910248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal aberrations evaluated by CGH, FISH and GTG-banding in a case of AIDS-related Burkitt's lymphoma.
    Zunino A; Viaggi S; Ottaggio L; Fronza G; Schenone A; Roncella S; Abbondandolo A
    Haematologica; 2000 Mar; 85(3):250-5. PubMed ID: 10702812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oncogenic potential of Epstein-Barr virus.
    Lam KM; Crawford DH
    Crit Rev Oncog; 1991; 2(3):229-45. PubMed ID: 1653621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomere size and telomerase activity in Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cell lines.
    Mochida A; Gotoh E; Senpuku H; Harada S; Kitamura R; Takahashi T; Yanagi K
    Arch Virol; 2005 Oct; 150(10):2139-50. PubMed ID: 15986178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.